RL
76
4
JBHT
26
6
AAL
27
7
MCHP
52
2
PYPL
66
4
HST
42
2
UNM
61
4
HPE
61
4
MDT
57
4
BLK
61
4
CINF
53
2
PH
73
2
NUE
50
2
NSC
53
3
NEE
42
4
EFX
74
2
LLY
59
6
EMN
48
5
LMT
54
-6
NTRS
62
2
RL
76
4
JBHT
26
6
AAL
27
7
MCHP
52
2
PYPL
66
4
HST
42
2
UNM
61
4
HPE
61
4
MDT
57
4
BLK
61
4
CINF
53
2
PH
73
2
NUE
50
2
NSC
53
3
NEE
42
4
EFX
74
2
LLY
59
6
EMN
48
5
LMT
54
-6
NTRS
62
2
Financhill
Back

Global Cord Blood 10K Form

Buy
57

CORBF
Global Cord Blood

Last Price:
$1.06
Seasonality Move:
-2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CORBF News And Ratings

See the #1 stock for the next 7 days that we like better than CORBF

CORBF Financial Statistics

Sales & Book Value

Annual Sales: $193.5M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0.19

Profitability

Net Income (TTM): $0
Gross Margin: $165M
Return on Equity: 0%
Return on Assets: 0%

Global Cord Blood Earnings Forecast

Key Global Cord Blood Financial Ratios

  • The Gross Profit Margin over the past 14 years for CORBF is 85.26%.
  • The Selling, General & Administrative Expenses for CORBF have been equal to 34.49% of Gross Profit Margin.
  • The Research & Development expenses have been 1.79% of Revenue.
  • The Interest Expense is 1.37% of Operating Income.
  • The Net Earning history of CORBF is 40.30% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Global Cord Blood Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CORBF
Website: globalcordbloodcorp.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 1.65
Forward P/E Ratio: 0

CORBF Technical Analysis vs Fundamental Analysis

Buy
57
Global Cord Blood (CORBF) is a Buy

Is Global Cord Blood a Buy or a Sell?